The impact of COVID-19 on some aspects of laboratory activities


Aci R., Keskin A.

Rivista Italiana della Medicina di Laboratorio, cilt.18, sa.2, ss.85-90, 2022 (Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 18 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.23736/s1825-859x.22.00143-8
  • Dergi Adı: Rivista Italiana della Medicina di Laboratorio
  • Derginin Tarandığı İndeksler: Scopus, EMBASE
  • Sayfa Sayıları: ss.85-90
  • Anahtar Kelimeler: COVID-19, Laboratories. Pre-analytical error, Pandemics
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Background: The COVID-19 outbreak has affected the activities of many fields. This study aimed to evaluate the impact of the COVID-19 outbreak on laboratory activity. Methods: The data of the study were obtained from a single-center homogeneous group in the biochemistry laboratory of Samsun Training and Research Hospital. These data were divided into two patient groups: Group A (Pre-COVID-19 outbreak period patients) and Group B (COVID-19 outbreak period patients). Erythrocyte sedimentation rate (ESR), hormones, coagulation, glycosylated hemoglobin, biochemistry, complete blood count (CBC), blood gas, urine sample types, and pre-analytical errors were included. The data of the two groups were compared with the chi-square test. Results: The number of samples requested per patient was 0.62 in Group A and 0.67 in Group B. The reduction rate detected in biochemistry (P<0.001), blood gas (P<0.001) and CBC (P=0.007) sample types was lower than the reduction rate detected in the number of patients in Group B. On the other hand, the reduction rate detected in ESR (P<0.001), coagulation (P=0.045), glycosylated hemoglobin (P<0.001), and urine (P<0.001) sample types was higher than the reduction rate detected in the number of patients in Group B. The pre-analytical error rate in Group B (0.46%) was higher than in Group A (0.29%) (P<0.001). The rate of hemolyzed samples was higher, and the rate of the incorrect request was lower in Group B. Conclusions: Laboratory test requests per patient and pre-analytical error rates increased significantly during the COVID-19 outbreak.